Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
75,275,225
-
Share change
-
-5,853,082
-
Total reported value
-
$334,978,279
-
Price per share
-
$4.45
-
Number of holders
-
74
-
Value change
-
-$48,128,612
-
Number of buys
-
36
-
Number of sells
-
35
Institutional Holders of RUBIUS THERAPEUTICS INC - COM (RUBY) as of Q1 2020
As of 31 Mar 2020,
RUBIUS THERAPEUTICS INC - COM (RUBY) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,275,225 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, BAILLIE GIFFORD & CO, Artal Group S.A., BlackRock Inc., VANGUARD GROUP INC, ARCH VENTURE CORP, Capital World Investors, JPMORGAN CHASE & CO, and HarbourVest Partners LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.